➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Express Scripts
Mallinckrodt
Moodys
Harvard Business School
Boehringer Ingelheim

Last Updated: September 26, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for GWP42006

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for GWP42006?

GWP42006 is an investigational drug.

There have been 4 clinical trials for GWP42006. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2019.

The most common disease conditions in clinical trials are Seizures, Child Development Disorders, Pervasive, and Autistic Disorder. The leading clinical trial sponsors are GW Research Ltd and [disabled in preview].

There are twenty-nine US patents protecting this investigational drug and one hundred and forty-eight international patents.

Recent Clinical Trials for GWP42006
TitleSponsorPhase
Safety and Tolerability of Cannabidivarin (CBDV) in Children and Young Adults With Autism Spectrum DisorderGW Research LtdPhase 2
A Study of GWP42006 in People With Focal Seizures - Part BGW Research LtdPhase 2
A Study of GWP42006 in People With Focal Seizures - Part AGW Research LtdPhase 2

See all GWP42006 clinical trials

Clinical Trial Summary for GWP42006

Top disease conditions for GWP42006
Top clinical trial sponsors for GWP42006

See all GWP42006 clinical trials

US Patents for GWP42006

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
GWP42006   Start Trial Enhanced smokable therapeutic cannabis product and method for making same CMG PARTNERS, INC. (San Jose, CA)   Start Trial
GWP42006   Start Trial Cannabis-based therapeutic product for treatment of chronic pain CMG PARTNERS, INC. (San Jose, CA)   Start Trial
GWP42006   Start Trial Cannabinoid composition and products including .alpha.-tocopherol Constance Therapeutics, Inc. (San Francisco, CA)   Start Trial
GWP42006   Start Trial Food and beverage compositions infused with lipophilic active agents and methods of use thereof   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for GWP42006

Drugname Country Document Number Estimated Expiration Related US Patent
GWP42006 World Intellectual Property Organization (WIPO) 2018226899 2037-06-06   Start Trial
GWP42006 World Intellectual Property Organization (WIPO) 2018227017 2037-06-06   Start Trial
GWP42006 World Intellectual Property Organization (WIPO) 2019173242 2037-06-06   Start Trial
GWP42006 World Intellectual Property Organization (WIPO) 2019178088 2037-06-06   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Express Scripts
Mallinckrodt
Moodys
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.